neurology

News

NICE says final 'no' to BMS' Zeposia for multiple sclerosis

NICE has issued a final “no” to Bristol-Myers Squibb’s oral MS drug Zeposia (ozanimod), in a decision that prevents access for patients in England and Wales.

News

Closeup of X-ray photography of human brain

Exscientia starts trials of AI-designed Alzheimer's drug

Exscientia has advanced a drug candidate for Alzheimer's disease into human testing, the third clinical-stage project for the UK specialist in artificial intelligence (AI) based drug discov

News

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Roche's Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending the treatment options for people with the life-threatenin

News

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.

News

ABPI’s Sheuli Porkess on how COVID-19 could improve clinical trial conduct

Safety study pushes back phase 3 trial of Newron's schizophr...

Switzerland’s neurology specialist Newron must hold off starting a phase 3 study of its schizophrenia drug evenamide to complete a small study to show safety at a higher dose, causing a fur

News

FDA grew too close to Biogen during Alzheimer's drug develop...

The FDA got too close to Biogen during the development of the Alzheimer’s drug aducanumab, according to its own expert advisers who are urging the regulator to reject it in the coming weeks

NICE says final 'no' to BMS' Zeposia for multiple sclerosis

Exscientia starts trials of AI-designed Alzheimer's drug

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Safety study pushes back phase 3 trial of Newron's schizophr...

FDA grew too close to Biogen during Alzheimer's drug develop...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

neurology

Editor's Picks